{
  "doi": "10.1016/j.cej.2023.144177",
  "QAs": [
    {
      "question": "What is the main target for various therapeutic agents in cancer treatment?",
      "answer": "The cell nucleus is the main target for various therapeutic agents in cancer treatment.",
      "difficulty": "easy",
      "type": "factual"
    },
    {
      "question": "What are the primary methods of treating cancers mentioned in the text?",
      "answer": "The primary methods of treating cancers mentioned are surgery, radiation therapy, and chemotherapy.",
      "difficulty": "easy",
      "type": "factual"
    },
    {
      "question": "What is the role of Zn-QCDM in targeted drug delivery for cancer treatment?",
      "answer": "Zn-QCDM is used for nucleus-targeted drug delivery, enhancing the therapeutic effect by delivering drugs directly to the nucleus.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "How does Zn-QCDM achieve nucleus-targeting in cancer cells?",
      "answer": "Zn-QCDM achieves nucleus-targeting through strong π-π stacking and Zn-O coordination with unpaired bases on RNA, leading to selective distribution in the cell nucleus.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "What are the advantages of using Zn-QCDM for drug delivery in cancer therapy?",
      "answer": "The advantages include high drug loading capacity, controlled drug release, enhanced photostability, and significant inhibition of tumor growth.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM exhibits strong red photoluminescence under UV light irradiation.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "True or False: The cytotoxicity of CPT@Zn-QCDM was significantly higher than that of free CPT at the same dose.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What is the significance of the study on Zn-QCDM in the context of cancer therapy?",
      "answer": "The study on Zn-QCDM is significant as it provides a structure-precise drug carrier with clear targeting property and mechanism interpretation, offering a promising approach for nucleus-targeted drug delivery in cancer therapy.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM was primarily internalized through energy-dependent clathrin-mediated endocytosis.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What challenges does Zn-QCDM address in the field of drug delivery for cancer treatment?",
      "answer": "Zn-QCDM addresses challenges such as enhancing chemotherapy effectiveness, reducing toxicity, overcoming drug resistance, and providing visible tracking for delivery procedures.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: The drug release efficiency of CPT from CPT@Zn-QCDM reached approximately 90% after equilibriums.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "How does the structure of Zn-QCDM contribute to its function in drug delivery?",
      "answer": "The structure of Zn-QCDM, featuring 1D ‘-O-Zn-O-C’ chain-like structure and the π-π stacking between the QCDM ligands, contributes to its function in drug delivery by facilitating high drug loading, controlled release, and nucleus-targeting.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM has a high loading capacity for CPT of 131%.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What experimental methods were used to study the properties and functions of Zn-QCDM?",
      "answer": "Experimental methods used include NMR, HR-MS, XRD, TG, FT-IR spectroscopy, SEM, Bio-TEM, DLS analysis, UV–Vis-NIR and photoluminescence spectroscopies, and in vitro/in vivo assays.",
      "difficulty": "hard",
      "type": "factual"
    },
    {
      "question": "True or False: The study provides a promising approach for nucleus-targeted drug delivery in cancer therapy.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What are the potential clinical implications of the findings on Zn-QCDM for cancer therapy?",
      "answer": "The potential clinical implications include the development of more effective cancer treatments with reduced side effects, overcoming drug resistance, and providing a new strategy for targeted drug delivery to the nucleus.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM's photostability is essential for its application in bioimaging and optoelectronics.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "How does the study on Zn-QCDM contribute to the field of nanomedicine?",
      "answer": "The study on Zn-QCDM contributes to the field of nanomedicine by introducing a novel nanocarrier with enhanced drug delivery capabilities, nucleus-targeting efficiency, and potential for bioimaging, paving the way for advanced cancer therapeutics.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: The research on Zn-QCDM demonstrates the importance of structure-precision in the design of drug carriers.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What future research directions are suggested by the findings on Zn-QCDM?",
      "answer": "Future research directions include exploring the mechanism of action of Zn-QCDM in greater detail, testing its efficacy with other drugs and in different cancer models, and further optimizing its structure for improved performance.",
      "difficulty": "hard",
      "type": "reasoning"
    }
  ]
}
